Phase II study of atezolizumab for pretreated advanced / recurrent non-small cell lung cancer with idiopathic interstitial pneumonia (TORG1936 / AMBITIOUS study)

  • S. Ikeda, T. Kato, H. Kenmotsu, T. Ogura, S. Iwasawa, T. Iwasawa, R. Kasajima, Y. Miyagi, T. Misumi, T. Yamanaka, H. Okamoto
  • Annals of Oncology, November 2019, Elsevier
  • DOI: 10.1093/annonc/mdz437.060

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Satoshi Ikeda